# Antiretroviral Speed Access Program

> **NCT04897243** · — · UNKNOWN · sponsor: **Dr. Bertrand Lebouche** · enrollment: 75 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Biktarvy
- **BEHAVIORAL:** Patient Experience

## Key facts

- **NCT ID:** NCT04897243
- **Lead sponsor:** Dr. Bertrand Lebouche
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897243, "Antiretroviral Speed Access Program". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04897243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*